Comparison of microbiological assay and HPLC-UV for determination of fluconazole in capsules

Brazilian Journal of Pharmaceutical Sciences

Volumn 45, Issue 4, 2009, Pages 693-700

  Queiroz, Kelly Marques ^a   Silva, Maria Luiza Martins ^a   Prado, Nathália Duque ^a   Lima, Paulo Marcelo Andrade ^a   Diniz, Rosiane Dias Lopes ^a   César, Isabela Costa ^b   Pianetti, Gerson Antônio ^b   Santos, Daniel Assis ^a  

^a UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Fluconazole quantitative determination; High performance liquid chromatography; Microbiological assay agar diffusion

Indexed keywords

FLUCONAZOLE;

ACCURACY; AGAR DIFFUSION; ARTICLE; BIOASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG CAPSULE; DRUG DETERMINATION; DRUG FORMULATION; DRUG INDUSTRY; DRUG RESEARCH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; NONHUMAN; PROSPECTIVE STUDY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 77950665921     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502009000400012     Document Type: Article

References (31)

1. ABDEL-MOETY, E. M.; KHATTAB, F. I.; KELANI, K. M.; ABOUAL-ALAMEIN, A. M. Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations. Farmaco, v.57, p.931-938, 2002.
2. ADAMS, A. I. H.; STEPPE, M.; FRÖEHLICH, P. E.; BERGOLD, A. M. Comparison of microbiological and UV-spectrophotometric assays for determination of voriconazole in tablets. J. AOAC Int., v.89, p.960-965, 1996.
3. BRITISH Pharmacopoeia. London: Her Majesty's Stationary Office, 2007. p.835-836
4. CLINICAL AND LABORATORY STANDARD INSTITUTE (CLSI). M27A2: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. 2.ed. Wayne: Clinical and Laboratory Standards Institute, 2002. p.1-26.
5. CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Wayne: Clinical and Laboratory Standards Institute, 2002. (Approved standard M38-A).
6. COHEN, L. G.; DIBIASO, A.; LISCO, S. J.; HURFORD, W. E. Fluconazole serum concentration and pharmacokinetics in an obese patient. Pharmacotherapy, v.17, p.1023-1026, 1997. (Pubitemid 27415107)
7. ESPINEL-INGROF, A.; SHADOMY, S.; FISCHER, J. F. Bioassay for miconazole. Antimicrob. Agents Chemother., v.11, p.365-368, 1977.
8. FARMACOÉIA Brasileira. 4.ed. Atheneu: São Paulo, 1988. p.287.1-287.2.
9. FIGUEIREDO, V. T.; SANTOS, D. A.; RESENDE, M. A.; HAMDAN, J. S. Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections. Mycopathol., v.164, p.27-33, 2007.
10. GARCIA-HERMOSO, D.; DROMER, F.; IMPROVISIS, L.; PROVOST, F.; DUPONT, B. Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole. Antimicrob. Agents Chemother., v.39, p.656-660, 1995.
11. HARRIS, S. C.; WALLACE, J. E.; FOULDS, G.; RINALDI, M. G. Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection. Antimicrob. Agents Chemother., v.33, p.714-716, 1989.
12. HOSTETLER, J. S.; HEYKANTS, J.; CLEMONS, K. V.; WOESTENBORGHS, R.; HANSON, L. H.; STEVENS, D. A. Discrepancies in bioassay and chromatograph determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations. Antimicrob. Agents Chemother., v.37, p.2224-2227, 1993.
13. HÜLSEWEDE, J. W.; DERMOUMI, H. Serum level determination of fluconazole by high-performance liquid chromatography and bioassay. Zentralbl. Bakteriol., v.283, p.492-496, 1996. (Pubitemid 126570719)
14. KEEVIL, B. G.; NEWMAN, S.; LOCKHART, S.; HOWARD, S. J.; MOORE, C. B.; DENNING, D. W. Validation of an assay for voriconazole in serum samples using liquid chromatograph-tandem mass spectrometry. Ther. Drug Monit., v.26, p.650-657, 1994.
15. KIM, S. S.; IM, H. T.; KANG, I. M.; LEE, H. S.; LEE, H. W.; CHO, S. H.; KIM, J. B.; LEE, K. T. An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study. J. Chromatogr. B., v.852, p.174-179, 2007. (Pubitemid 46830110)
16. KOKS, C. H.; MEENHORST, P. L.; HILLEBRAND, M. J.; BULT, A.; BEIJNEN, J. H. Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules. Antimicrob. Agents Chemother., v.40, p.1935-1937, 1996.
17. LAW, D.; MOORE, C. B.; DENNING, D. W. Bioassay for serum itraconazole concentrations usin hydroxyitraconazole standards. Antimicrob. Agents Chemother., v.38, p.1561-1566, 1994.
18. LIMA, P. M. A.; PRADO, N. D.; SILVA, M. L. M.; DINIZ, R. D. L.; QUEIROZ, K. M.; CÉSAR, I. C.; PIANETTI, G. A.; SANTOS, D. A. Determination of ketoconazole in capsules by HPLC and microbiological assay. J. AOAC Internat., v.92, p.1076-1081, 2009.
19. MARCHETTI, O.; MAJCHERCZYK, P. A.; GLAUSER, M. P.; BILLE, G.; MOREILLON, P.; SANGLARD, D. Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles. Antimicrob. Agents Chemother., v.45, p.696-700, 2001.
20. MATHY, F. X.; VROMAN, B.; NTIVUNWA, D.; WINNE, A. J. D.; VERBEECK, R. K.; PRÉAT, V. On-line determination of fluconazole in blood an dermal rat microdialysates by microbore high-performance liquid chromatograph. J. Chromat. B., v.787, p.323-331, 2003.
21. MORAES, L.A.; LERNER, F.E.; MORAES, M.E.; MORAES, M.O.; CORSO, G.; DE NUCCI G. Fluconazole bioequivalence study: quantification by tandem mass spectrometry. Ther. Drug Monit., v.21, p.200-207, 1999.
22. ODDS, F. C.; DUPONT, B.; RINALDI, M. G.; STEVENS, D. A.; WARNOCK, D. W.; WOESTENBORGHS, R. Bioassays for itraconazole blood levels: an interlaboratory collaborative study. J. Antimicrob. Chemother., v.43, p.723-727, 1999.
23. PASCUAL, A.; NIETH, V.; CALANDRA, T.; BILLE, J.; BOLAY, S.; DECOSTERD, L. A.; BUCLIN, T.; MAJCHERCAYK, P. A.; SANGLARD, D.; MARCHETTI, O. Variability of voriconazole plasma levels measured by new high-performance liquid chromatograph and bioassay methods. Antimicrob. Agents Chemother., v.51, p.137-143, 2007.
24. PEREA, S.; PENNICK, G. J.; MODAK, A.; FOTHERGILL, A. W.; SUTTON, D. A.; SHEEHAN, D. J.; RINALDI, M. G., Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob. Agents Chemother., v.44, p.1209-1213, 2000. (Pubitemid 30228296)
25. PORTA V.; CHANG, K. H.; STORPIRTIS, S. Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. Int. J. Pharm., v.288, p.81-86, 2005. (Pubitemid 39656457)
26. PURANJOTI, P.; KASINA, R.; TENJARLA, S. Microbiological and HPLC analysis of miconazole in skin, serum and phasesolubility studies. J. Clin. Pharm. Therap., v.24, p.445-450, 1999.
27. REX, J. H.; HANSON, L. H.; AMANTEA, M. A.; STEVENS, D. A.; BENNETT, J. E. Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography. Antimicrob. Agents Chemother., v.35, p.846-850, 1991.
28. SALGADO, H. R. N.; LOPES, C. C. G. O.; LUCCHESI, M. B. B. Microbiological assay for gatifloxacin in pharmaceutical formulations. J. Pharm. Biomed. Anal., v.40, p.443-446, 2006.
29. UNITED States Pharmacopoeia. 30.ed. Rockville: United States Pharmacopeial Convention, 2007. p.2137-2139
30. VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2 (R1) - ICH Harmonized Tripartite Guideline. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005. p. 1-13.
31. WARNOCK, D. W.; TURNER, A.; BURKE, J. Comparison of high performance liquid chromatograph and microbiological methods for determination of itraconazole. J. Antimicrob. Chemother., v.21, p.93-100, 1988.